S. Madden et al., BIOACTIVATION OF CARBAMAZEPINE IN THE RAT IN-VIVO - EVIDENCE FOR THE FORMATION OF REACTIVE ARENE OXIDE(S), Drug metabolism and disposition, 24(4), 1996, pp. 469-479
The metabolism of carbamazepine (CBZ) and its major metabolite in huma
ns, carbamazepine 10,11-epoxide (CBZ-E), was examined in the rat in vi
vo. Particular emphasis was placed on the identification of dihydrohyd
roxythio adducts, which are detoxication products of reactive arene ox
ide intermediates. Anesthetized and cannulated male Wistar rats were a
dministered [H-3]CBZ (25 mu g . kg(-1) or 25 mg . kg(-1)) or [H-3]CBZ-
E (25 mu g . kg(-1) or 25 mg . kg(-1)) intravenously and bile and urin
e collected for 5 hr. Less than 8% of drug was excreted in the urine f
or each dosing regimen. Biliary excretion accounted for 73.7 +/- 6.2 a
nd 41.8 +/- 6.2% (mean +/- SD, N = 4) of administered CBZ (25 mu g . k
g(-1) and 25 mg . kg(-1) respectively) and 47.6 (N = 2) and 28.1 +/- 6
.0% of administered CBZ-E (25 mu g . kg(-1) and 25 mg . kg(-1), respec
tively). The major route of metabolism of both CBZ and CBZ-E was N-glu
curonidation. In rats given CBZ (25 mg . kg(-1)), the N-glucuronide of
the parent compound accounted for 12.6 +/- 2.6% of the dose, whereas
CBZ-E N-glucuronide accounted for 12.3 +/- 3.8% of the dose. At the lo
wer dose of 25 mu g . kg(-1), these accounted for 18.6 +/- 3.0 and 36.
7 +/- 4.7% of the dose, respectively. Similarly, for rats given CBZ-E
(25 mg . kg(-1)), the N-glucuronide of the parent compound was the maj
or metabolite, accounting for 19.1 +/- 4.5% of the dose. O-glucuronide
s were relatively minor metabolites of both drugs. Glutathione adducts
were identified in the bile of both groups of animals. Although these
adducts were relatively minor metabolites of CBZ-E (1.8% of the dose)
, they were more substantial products of the metabolism of CBZ. Three
isomeric glutathionyl dihydrohydroxy-CBZ adducts were identified by LC
/MS. They collectively accounted for 5.8 +/- 0.9% of the dose. In conc
lusion, we have provided evidence, in rats, for the generation of a re
active arene oxide species from CBZ. If not adequately detoxified, via
conjugation with glutathione, this has the potential to initiate cell
ular damage. In humans, a similar mechanism may be involved in CBZ-ass
ociated hypersensitivity.